Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

This study aims to improve how doctors predict a woman's future risk of developing breast cancer by combining information from tissue samples, imaging (like mammograms or MRI), and genetics. **You may be eligible if...** - You are a woman between 18 and 100 years old - You had a benign (non-cancerous) breast biopsy at Mayo Clinic between 2002 and 2022 **You may NOT be eligible if...** - You are male - You have had a prior or current diagnosis of breast cancer - You were diagnosed with breast cancer within 6 months of your benign biopsy - You declined to participate in research - You had both breasts surgically removed (bilateral mastectomy) at the same time as or after your biopsy Talk to your doctor to see if this trial is right for you.